Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Net Cash Flow (2019 - 2026)

Viatris (VTRS) posted Net Cash Flow of -$912.4 million for Q2 2026, down 297.53% on a QoQ basis from $461.9 million in Q1 2026, and down 367.42% year-over-year from $341.2 million in Q2 2025.

Analysis

Viatris (VTRS) Net Cash Flow (2019 - 2026) Analysis & Trends

Viatris has reported Net Cash Flow for 8 years, with the latest figure at -$912.4 million in Q2 2026.

  • On a quarterly basis, Net Cash Flow fell 367.42% year-over-year to -$912.4 million in Q2 2026; TTM through Jun 2026 was $335.6 million, a 193.14% increase from a year earlier, with the FY2025 full-year figure at $594.3 million, up 362.04% from the prior year.
  • Net Cash Flow was -$912.4 million for Q2 2026 at Viatris, down from $461.9 million in the prior quarter.
  • The five-year high for Net Cash Flow was $937.7 million in Q3 2024, with the low at -$1.1 billion in Q4 2024.
  • Average Net Cash Flow over 5 years is $13.7 million, with a median of $19.0 million recorded in 2024.
  • The largest YoY upside for Net Cash Flow was 14625.53% in 2023 against a maximum downside of 1302.88% in 2023.
  • Over 5 years, Net Cash Flow stood at $596.5 million in 2022, then plunged by 155.47% to -$330.9 million in 2023, then sank by 234.3% to -$1.1 billion in 2024, then soared by 133.29% to $368.2 million in 2025, then slumped by 347.8% to -$912.4 million in 2026.
  • The last three Net Cash Flow figures came in at -$912.4 million (Q2 2026), $461.9 million (Q1 2026), and $368.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -81.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -912.40 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -44.45 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -64.63 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 528.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 78.82 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 48.97 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 52.66 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -912.40 Mn
Mar 31, 2026 461.90 Mn
Dec 31, 2025 368.20 Mn
Sep 30, 2025 417.90 Mn
Jun 30, 2025 -195.20 Mn
Mar 31, 2025 3.40 Mn
Dec 31, 2024 -1.11 Bn
Sep 30, 2024 937.70 Mn
Jun 30, 2024 -93.00 Mn
Mar 31, 2024 34.70 Mn
Dec 31, 2023 -330.90 Mn
Sep 30, 2023 682.70 Mn
Jun 30, 2023 134.80 Mn
Mar 31, 2023 -753.00 Mn
Dec 31, 2022 596.50 Mn
Sep 30, 2022 -4.70 Mn
Jun 30, 2022 -59.20 Mn
Mar 31, 2022 62.60 Mn
Dec 31, 2021 -45.20 Mn
Sep 30, 2021 89.90 Mn